Home » Stocks » ISCO

International Stem Cell Corporation (ISCO)

Stock Price: $0.9299 USD -0.0301 (-3.14%)
Updated Feb 26, 2021 3:54 PM EST - Market closed
Market Cap 7.01M
Revenue (ttm) 8.49M
Net Income (ttm) -4.72M
Shares Out 7.54M
EPS (ttm) -0.63
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $0.9299
Previous Close $0.9600
Change ($) -0.0301
Change (%) -3.14%
Day's Open 0.8899
Day's Range 0.8899 - 0.9299
Day's Volume 575
52-Week Range 0.3 - 1.08

News

There are no news available yet.

About ISCO

International Stem Cell Corporation focuses on the development of therapeutic and biomedical products worldwide. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; liver cells to treat various congenital and acquired liver diseases; and islet cells for the treatment of diabetes. The company also develops, manufactures, and markets skincare... [Read more...]

Industry
Biotechnology
Founded
2001
CEO
Dr. Andrey Semechkin
Employees
39
Stock Exchange
OTCMKTS
Ticker Symbol
ISCO
Full Company Profile

Financial Performance

In 2019, ISCO's revenue was $9.47 million, a decrease of -14.58% compared to the previous year's $11.09 million. Losses were -$4.27 million, 100.1% more than in 2018.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for ISCO is 0.54, which is a decrease of -41.93% from the latest price.

Price Target
$0.54
(-41.93% downside)